Introducing Tixel-i is a 2-minute treatment for Dry Eye Disease with no expression needed. Best in class results and longer lasting relief with proven safety. Tixel is the next generation of energy-based technology, built on over a decade of scientific and clinical innovation.
SUN Pharma
Sun Pharma is a global pharmaceutical company with operations in over 100 countries, including our ophthalmic division, where we are committed to pursuing life-changing technology in eye care. Discover a brighter future in eye care. Learn more at www.SunPharma.com | Sun Pharma is the 4th largest specialty generic pharmaceutical company in the world, providing high-quality, affordable medicines in over 150 countries. Our mission is to enhance people’s lives with innovative and quality generic, branded, and over-the-counter medicines, providing exceptional value in our communities. In the US, Sun Pharma is focused on helping patients in Dermatology, Oncology, Ophthalmology, and Neurology.
SIFI S.p.A
SIFI, leading ophthalmic company, headquartered in Italy, since 1935 develops, manufactures and markets innovative therapeutic solutions for patients with ophthalmic disorders. SIFI portfolio includes innovative pharmaceuticals, medical devices, food supplements and an orphan drug for rare disease (Acanthamoeba Keratitis). From 2025 SIFI is part of FAES Farma Group.
OCuSOFT Inc.
Since 1986 OCuSOFT®, most recognized for its #1 Doctor Recommended Brand of Eyelid Cleansers, has served the ophthalmic community with a unique selection of proprietary brands including OCuSOFT® Lid Scrub® Eyelid Cleansers and OCuSOFT® Thermal 1-Touch® Localized Heat Therapy. Please visit our booth to learn more!
Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across development, treatment, and outcomes. OTX-TKI (also known as AXPAXLI™), Ocular’s investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX™ proprietary bioresorbable hydrogel-based technology. It is currently in Phase 3 clinical trials to advance wet age-related macular degeneration (AMD) and diabetic retinopathy (DR) treatment, aiming to improve long-term outcomes while reducing the frequency of injections. | Ocular Therapeutix, Inc. is a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions.
Ocubio, LLC
We support licensed eye care professionals with solutions, education, and validated processes to provide personalized ocular therapies — ensuring quality, consistency, and confidence at every step.
Oasis Medical, Inc.
OASIS Medical is a US based manufacturer and distributor of vision care solutions serving the eye care industry for over 37 years. As a privately owned business, OASIS Medical is nourishing and sustaining the eye care community for the long term.
iPothecary
iPothecary is a physician-guided platform that enables ophthalmology and optometry practices to recommend and deliver trusted eye care products directly to patients. By connecting patients with curated, doctor-recommended treatments, iPothecary helps practices extend care beyond the exam room, improve treatment adherence, and simplify access to professional-grade ocular therapies.
EyePromise (Formerly PRN Physician Recommended Nutriceuticals)
EyePromise is an eye health company created with a relentless commitment to science-backed eye health solutions dedicated to our shared passion for protecting the precious gift of sight.
DefEYE, Inc.
DefEYE, Inc. is on a mission to transform and personalize therapeutic approaches in eye care. The company focuses on delivering innovative decellularized biologic solutions that optimize treatment and management of various eye care conditions, including ocular surface diseases, pterygium surgery, and other surgical interventions. To learn more, visit www.defeye.com.